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Background
The ability to modify a population of blood cells with both an antigen
of interest and an identification-recovery label, infuse them into the
circulation of an animal, and then visualize or recover a sample of the
infused cells some hours-days later for analysis, is now possible through
the use of FSL (function-spacer-lipid) constructs.
FSL constructs are analogous in structure to a flower and consist of three
components; a unctional head group (like the flower head), a pacer
(like a stalk) and a diacyl ipid tail (the anchoring roots). All FSLs are
biocompatible and allow users to introduce novel unctional moieties
to the membrane surface of living cells .
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Materials & Methods
Results
FSL blood group A (FSL-A), FSL-GB3 and FSL-biotin KODE constructs were
supplied by KODE Biotech (www.kodebiotech.com) - figure 1
Murine kodecytes bearing both blood group A antigen and biotin
(A+biotin kodecytes) were created by incubating equal volumes of
packed murine red cells with a solution containing ( ) FSL-biotin
and (10 ) of FSL-A (or FSL-GB3 as negative control). These A+biotin
kodecytes or GB3+biotin kodecytes were then transfused (2 into the
circulation of laboratory mice with or without anti-A (stimulated by
immunisation with salivary blood group A substance). Blood was
sampled ( ) at specific time points post transfusion and, using
the secondary reagent surviving kodecytes could
be identified in blood films and fluorescence microscopy (figure 2).
Additionally b
Anti-A status of all mice was determined using
inkjet printed FSL-A constructs in an EIA method .
50µg/ml
0µg/ml
0µl)
50µl
avidin Alexa Fluor®,
y using 50µl of avidin-coated agarose beads (Pierce),
in cards transfused biotin kodecytes could be purified from a 5µl
whole blood sample (figure 4) for further in vitro analysis
after recovery by vortexing from the avidin beads.
4
Conclusions
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Transfused kodecytes could be identified by fluorescence microscopy
(figure 3) in blood films for periods of up to 96 hours in A antigen
compatible (series 2) and control (FSL-GB3+biotin and FSL-Biotin alone)
mice (series 3-6). When A+biotin-kodecytes were infused into mice with
circulating anti-A (series 1) they had significantly reduced (<2hr) red cell
survival times (table 1). Using avidin-coated agarose beads transfused
A+biotin-kodecytes could be purified from whole blood samples and
subjected to further blood group analysis (figure 4).in vitro
As part of a project investigating ABO incompatible transfusions murine
blood group A kodecytes were created with FSL-A. In order to visualise
and recover these infused cells they were also co-labled with FSL-biotin.
Transfusion survivals were able to be monitored by detecting kodecytes
via their FSL-biotin labels and fluorescence microscopy. Surviving
transfused kodecytes were also able to be recovered days after
transfusion from non-transfused cells by passage through avidin beads
which trapped the FSL-biotin kodecytes. These recovered kodecytes
could then be analysed in separate tests. The results of this
research demonstrate a novel technique for creating deliberate
antigen-antibody incompatibility, determining cell survival and
recovery of transfused cells for further analysis.
in vitro
in vivo
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Figure 1. Schematic of FSL-A, the anti-A "incompatible" blood
group antigen, FSL-GB3 the "benign" antigen, and
FSL-biotin, the visualisation and cell recovery label.
Series 2 A+biotin-kodecyte survival
@ 2 hours in anti-A negative mouse
Series 1 A+biotin-kodecyte survival
@ 2 hours in anti-A positive mouse
Figure 3. Composite DIC
and fluorescence image
of series 1 & 2 transfusion
Table 1.
Figure 2. FSL-A was inkjet printed in microwell format.
Anti-A status was determined by the appearance of the
letter A in the microwell following EIA development
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Figure 4. Surviving transfused A+biotin
kodecytes can be recovered from whole
blood by passage through avidin beads.
Recovered kodecytes can then be shown
to be group A by further analysis on
normal blood grouping anti-A gels
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